Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Pena Luis C., holds the title of President & CEO at Evommune, Inc..
On 2026-11-13, the insider transacted 2,176,522 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Pena Luis C. (President & CEO) sold $0 of $EVMN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.